These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36238306)
21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
22. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment. Zawilska JB; Lagodzinski A; Berezinska M J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123 [TBL] [Abstract][Full Text] [Related]
28. Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series. Mehta Y; Mehta C; Nanda S; Kochar G; George JV; Singh MK J Med Case Rep; 2021 Sep; 15(1):476. PubMed ID: 34535189 [TBL] [Abstract][Full Text] [Related]
29. The effect of omega‑3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID‑19: a randomized clinical trial. Safaei Ardestani SZ; Rahideh ST J Transl Med; 2022 Jan; 20(1):32. PubMed ID: 35033110 [No Abstract] [Full Text] [Related]
30. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
31. Pharmaconutrition: acute fatty acid modulation of circulating cytokines in elderly patients in the ICU. Barros KV; Cassulino AP; Schalch L; Della Valle Munhoz E; Manetta JA; Calder PC; Flor Silveira VL JPEN J Parenter Enteral Nutr; 2014 May; 38(4):467-74. PubMed ID: 23471207 [TBL] [Abstract][Full Text] [Related]
32. Rationale and use of n-3 fatty acids in artificial nutrition. Calder PC Proc Nutr Soc; 2010 Nov; 69(4):565-73. PubMed ID: 20441676 [TBL] [Abstract][Full Text] [Related]
33. Omega 3 Fatty Acids and COVID-19: A Comprehensive Review. Hathaway D; Pandav K; Patel M; Riva-Moscoso A; Singh BM; Patel A; Min ZC; Singh-Makkar S; Sana MK; Sanchez-Dopazo R; Desir R; Fahem MMM; Manella S; Rodriguez I; Alvarez A; Abreu R Infect Chemother; 2020 Dec; 52(4):478-495. PubMed ID: 33377319 [TBL] [Abstract][Full Text] [Related]
34. A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients. Huang P; Zuo Q; Li Y; Oduro PK; Tan F; Wang Y; Liu X; Li J; Wang Q; Guo F; Li Y; Yang L Front Immunol; 2022; 13():930673. PubMed ID: 35784318 [TBL] [Abstract][Full Text] [Related]
35. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs. Scala S; Pacelli R Front Immunol; 2020; 11():1201. PubMed ID: 32574268 [TBL] [Abstract][Full Text] [Related]
36. Supportive therapy during COVID-19: The proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure. Jardou M; Lawson R Med Hypotheses; 2021 Sep; 154():110661. PubMed ID: 34385045 [TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748 [TBL] [Abstract][Full Text] [Related]
38. Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes. Currie C; Myklebust TÅ; Bjerknes C; Framroze B Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000027 [TBL] [Abstract][Full Text] [Related]
39. The immune system and COVID-19: Friend or foe? Yazdanpanah F; Hamblin MR; Rezaei N Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542 [TBL] [Abstract][Full Text] [Related]